Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 12Carcinoid Tumor 7Somatostatinoma 4Neoplasms 4Insulinoma 4Glucagonoma 4Gastro-enteropancreatic neuroendocrine tumor 4Carcinoma, Islet Cell 4Vipoma 3Gastrinoma 3Adenoma, Islet Cell 3Acromegaly 3Pituitary Neoplasms 2Neoplasm Metastasis 2Carcinoma, Medullary 2Carcinoma 2Zollinger-Ellison Syndrome 1Serotonin Syndrome 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neuroendocrine Tumor G2 1Neoplastic Cells, Circulating 1Malignant Carcinoid Syndrome 1Head and Neck Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

lanreotide 1Sorafenib 1Radiofrequency Ablation 1Octreotide 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × Octreotide × Endocrine × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡